tops levine cancer institute: guideline-recommended biomarker testing in early-stage nsclc
Published 2 years ago • 107 plays • Length 7:30Download video MP4
Download video MP3
Similar videos
-
7:26
tops levine cancer institute: best practices in unresectable stage iii non-small cell lung cancer
-
8:02
lcc importance of biomarker testing in resectable nsclc
-
4:18
optimizing biomarker testing and ensuring appropriate treatment of metastatic nsclc
-
2:45
resectable nsclc and the importance of guideline-recommended molecular testing
-
10:38
tops: how tumor boards guide nsclc patient treatment decisions at adventhealth
-
9:52
tops: how best practices at adventhealth lead to optimal patient care in stage iv nsclc
-
12:26
the significance of biomarker testing in patient identification
-
7:58
tops levine cancer institute: lung cancer mdt communication and the impact of covid-19
-
48:19
lung cancer biomarker testing
-
9:39
tops: how best practices lead to optimal patient care in stage iii nsclc at adventhealth
-
8:23
molecular testing in patients with resectable or metastatic nsclc | for the lung cancer nursing team
-
10:20
lcc appropriate testing and treatment of stage iv nsclc (part 1 of 2 – testing)
-
10:53
tops: how adventhealth handles diagnosis and staging for optimal nsclc care
-
8:25
tops: how the mdt at adventhealth works together to improve nsclc patient care
-
5:05
tops western michigan: need for rapid diagnosis and treatment of es-sclc
-
1:53
tops mount sinai: cns metastases treatment in stage iv egfrm nsclc
-
11:22
addressing unmet needs for patients with resectable nsclc and the benefits of an mdt approach
-
1:09:51
lung cancer biomarkers & targeted therapies - webinar
-
56:16
biomarker testing for lung cancer webinar